Categorías
90 Day Fiance

Shekinah Garner Sparks Outrage: Promotes GLP-1 Weight Loss Shots Despite Not Being Overweight

Shekinah Garner, the ever-controversial star of 90 Day Fiance, has ignited a firestorm online after revealing she’s using GLP-1 weight loss injections—despite not being overweight. The TLC personality, known for her obsession with aesthetics and willingness to undergo cosmetic procedures, claimed in a recent post that she “microdoses” the drug and called it “amazing for so many things.”

Her statement, reshared by blogger @90dayfiance_alexa, triggered immediate backlash. Fans questioned the ethics of promoting a medical treatment typically reserved for obesity and chronic conditions.

“How is it life-saving for people who don’t really need it?” asked one follower, while another warned that spreading health misinformation without credentials could be dangerous.

The controversy deepened as speculation swirled around her relationship with Sarper Guven. Viewers recalled Sarper’s strict control over Shekinah’s weight, including his alleged demand that she stay under 128 pounds—reportedly even suggesting it be written into their prenup. Some fans now fear that Shekinah’s use of GLP-1 may be influenced by pressure from her partner, rather than personal health needs.

“She’s probably on them because Sarper doesn’t want her over 130 pounds,” one commenter wrote. Others defended Shekinah, arguing that many people use weight loss drugs to maintain their physique, not just to treat obesity.

Still, the debate rages on. Is Shekinah normalizing extreme beauty standards under the guise of wellness? Or is she simply sharing her personal journey in a world where appearance is currency? With rumors circulating that the couple may be filming for The Last Resort, fans are bracing for more revelations—and more controversy.

Deja un comentario

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *

This site uses cookies to enhance your experience. By continuing to the site you accept their use. More info in our cookies policy.     ACCEPT